Stefania Belli

6PUBLICATIONS
37CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 25, 2025
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives.

Federica Santoro, Francesco Merlino, Diego Brancaccio

|Aug 11, 2023
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer.

Stefania Belli, Ada Pesapane, Alberto Servetto

|May 31, 2023
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer.

Stefania Belli, Daniela Esposito, Alessandra Allotta

|Feb 07, 2023
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.

Ángel Guerrero-Zotano, Stefania Belli, Christoph Zielinski

|Jun 11, 2020
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?

Stefania Belli, Daniela Esposito, Alberto Servetto

Pageof 1